| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/07/2001 | EP0948361A4 Magnetic resonance blood pool agents |
| 02/06/2001 | US6184379 Rhodamine derivatives and the use thereof |
| 02/06/2001 | US6184254 Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors |
| 02/06/2001 | US6184214 Hydrolysis of 2-dichlorophosphoryloxy-acrylonitrile to form 2-hydroxyacrylamide-o-monophosphate; antiischemic agents for treating disorders due to the lack of atp |
| 02/06/2001 | US6184204 Peptides suitable for use in antigen specific immunosuppressive therapy |
| 02/06/2001 | US6183727 Detecting a pathology or target tissue by administering a zinc phthalocyanine dyes imaging material and exposing to radiation without damaging the mammalian host |
| 02/06/2001 | US6183726 Versatile hydrophilic dyes |
| 02/06/2001 | US6183725 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method |
| 02/06/2001 | US6183724 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them |
| 02/06/2001 | US6183723 Orally drug delivering vitamin b12 via a conjugated transcobalamin ii-cobalamin complex to a patient |
| 02/06/2001 | US6183497 Absorbable sponge with contrasting agent |
| 02/06/2001 | CA2119654C Particles for nmr imaging and method of manufacture |
| 02/01/2001 | WO2001007478A1 A p1 artificial chromosome (pac) vector for the expression of pituitary adenyl cyclase activating peptide receptor (pacap receptor) and transgenic animals comprising said vector |
| 02/01/2001 | WO1999066951A8 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 01/31/2001 | EP1072604A1 Calcium complex of (4R)-4-bis(carboxy-kappa.O)methyl amino-.kappa.N-6,9-bis (carboxy-.kappa.O)methyl-1-(4,4-diphenylcyclohexyl)oxy-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan- 11-yl acid-.kappa.N6,.kappa.N9,.kappa.O11 1-oxidato(6-)-,hexahydrogen, corresponding salts, pharmaceutical composition containing such complex, its therapeutic use and its use as additive as diagnostic agent as well as a process for preparing the complex |
| 01/31/2001 | EP1071451A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/31/2001 | EP1071423A1 Antagonists of gonadotropin releasing hormone |
| 01/31/2001 | EP1011623A4 Wet appliable sunscreen and makeup and method for testing sunscreens for efficacy |
| 01/30/2001 | US6180766 Nucleosides and oligonucleotides containing boron clusters |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180336 Labelling and selection of molecules |
| 01/30/2001 | US6180113 Used in tumor therapy and interventional radiology |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180087 Tunable indocyanine dyes for biomedical applications |
| 01/30/2001 | US6180086 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities, laser assisted guided surgery for detection of micrometastases of tumors |
| 01/30/2001 | US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities |
| 01/30/2001 | US6180083 Tropane derivatives useable in particular for in vivo detection of dopamine transporters |
| 01/30/2001 | CA2053268C Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 01/30/2001 | CA1341176C Macrocylic compounds |
| 01/25/2001 | WO2001005968A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/25/2001 | WO2001005438A1 Porous inorganic targeted ultrasound contrast agents |
| 01/25/2001 | WO2001005388A2 Use of a fatty derivative for the treatment of external secretiondisorders |
| 01/25/2001 | CA2377023A1 Porous inorganic targeted ultrasound contrast agents |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1070262A1 Pharmacological mri (phmri) |
| 01/24/2001 | EP1070140A1 Compositions and methods for treating cells having double minute dna |
| 01/24/2001 | EP1070047A2 Lipids |
| 01/24/2001 | EP1069888A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 01/24/2001 | CN1281345A Apparatus for fluid administration |
| 01/23/2001 | US6177562 Chelated complexes of paramagnetic metals with low toxicity |
| 01/23/2001 | US6177561 Preparation of acid amides and metallization of compounds |
| 01/23/2001 | US6177160 Storage stability |
| 01/23/2001 | US6177062 Contrast for ultrasound images |
| 01/23/2001 | US6177061 Contrast agents for diagnosis with using dispersion of injectable aqueous medium |
| 01/23/2001 | US6177060 Nmr or x-ray lymphography images |
| 01/23/2001 | US6177059 Drugs and complexes with lipids |
| 01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
| 01/23/2001 | CA2077760C Magnetic resonance imaging |
| 01/18/2001 | WO2001003620A1 Use of trypan blue to visualise the anterior lens capsule of the eye |
| 01/18/2001 | WO2000038579B1 Device and method for safe location and marking of a cavity and sentinel lymph nodes |
| 01/18/2001 | WO2000035492A3 Vitronectin receptor antagonist pharmaceuticals |
| 01/17/2001 | EP1068224A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 01/17/2001 | EP1067970A2 Diagnostic imaging of vascular abnormalities using vasomodification |
| 01/17/2001 | EP1067968A1 Methods for evaluating a compound for its effect on skin |
| 01/17/2001 | EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 01/17/2001 | EP1067930A1 Antagonists of gonadotropin releasing hormone |
| 01/17/2001 | EP1003501A4 Means of ascertaining an individual's risk profile for atherosclerotic disease |
| 01/17/2001 | EP0938299A4 Methods for the production of protein particles useful for delivery of pharmacological agents |
| 01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
| 01/16/2001 | US6174730 Administering carbon-13 labeled aromatic amino acid, alanine, methionine, fructose, or galactose before surgery; measuring level in exhaled carbon dioxide; administering labeled compound after surgery; measuring level; comparing values |
| 01/16/2001 | CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus |
| 01/11/2001 | WO2001002851A1 Method for screening targeting dds preparation |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002419A1 C3'-methylene hydrogen phosphonate oligomers and related compounds |
| 01/11/2001 | WO2001002050A2 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
| 01/11/2001 | WO2001002029A1 Agent for occluding blood vessels |
| 01/11/2001 | WO2001002013A1 Predicting immunotherapy effectiveness through delayed type hypersensitivity |
| 01/11/2001 | WO2001001767A1 Hydrocephaly model animals |
| 01/11/2001 | WO2000051646A3 Assay for emetic activity |
| 01/11/2001 | CA2378606A1 Agent for occluding blood vessels |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/10/2001 | EP1066537A1 MR METHODS FOR IMAGING PULMONARY AND CARDIAC VASCULATURE AND EVALUATING BLOOD FLOW USING DISSOLVED POLARIZED ?129 Xe |
| 01/10/2001 | EP1066402A1 Methods of screening agents for activity using teleosts |
| 01/10/2001 | EP0986340A4 Radiopaque solution for visualizing dental anatomy, pathological conditions, and iatrogenic events, and method of use |
| 01/10/2001 | EP0863770A4 Contrast medium and its use |
| 01/10/2001 | CN1060397C Magnetic resonance contrast medium for gastrointestinal tract |
| 01/09/2001 | US6172277 Inducing amyloid plaque deposition in rodent brain; infusing brain of rodent with solution comprising amyloid peptide, detecting amplified amount of amyloid plaque formation in the brain of rodent compare to control |
| 01/09/2001 | US6172218 Oligonucleotide tags for sorting and identification |
| 01/09/2001 | US6172214 Oligonucleotide tags for sorting and identification |
| 01/09/2001 | US6172201 Cellular receptor for HIV-1 Vpr essential for G2/M phase |
| 01/09/2001 | US6172080 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/09/2001 | US6171858 Proscess for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and uses thereof |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000621A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 01/04/2001 | WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | WO2001000246A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 01/04/2001 | WO2001000101A1 Biopsy site marker and process and apparatus for applying it |
| 01/04/2001 | WO2001000014A2 Test animal for atherosclerosis model and methods for testing and screening |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/04/2001 | CA2377265A1 Somatostatin agonists |
| 01/04/2001 | CA2377154A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 01/04/2001 | CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | CA2376714A1 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers |
| 01/03/2001 | EP1064953A2 Contrast media for diagnostic imaging comprising gas-filled microspheres |
| 01/03/2001 | EP1064360A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 01/03/2001 | EP1064013A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES |
| 01/03/2001 | EP1064005A1 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 01/03/2001 | EP0610333B1 Treated apatite particles for medical diagnostic imaging |
| 01/02/2001 | US6169592 Photosensitive resin plate with polyimide pattern edge portion having greater hardness than polyimide pattern portion |
| 01/02/2001 | US6168779 Endoscopy in and fluid collection from individual breast ducts holds great diagnostic promise for the identification of intermediate markers. much of the promise, however, cannot be realized until access to each and every duct in a patient's |